TNSN96035A1 - Derives de n-(3-benzofurannyl) uree - Google Patents

Derives de n-(3-benzofurannyl) uree

Info

Publication number
TNSN96035A1
TNSN96035A1 TNTNSN96035A TNSN96035A TNSN96035A1 TN SN96035 A1 TNSN96035 A1 TN SN96035A1 TN TNSN96035 A TNTNSN96035 A TN TNSN96035A TN SN96035 A TNSN96035 A TN SN96035A TN SN96035 A1 TNSN96035 A1 TN SN96035A1
Authority
TN
Tunisia
Prior art keywords
benzofurannyl
urea derivatives
urea
derivatives
benzofuranne
Prior art date
Application number
TNTNSN96035A
Other languages
English (en)
Inventor
Gabriele Braunlich Dr
Rudiger Fischer Dr
Mazen Es-Sayed Dr
Rolf Henning Dr
Michael Sperzel Dr
Karl-Heinz Schlemmer Dr
Ulrich Nielsch Dr
Stephen Tudhope Dr
Graham Sturton Dr
Trevor S Abram Dr
F Fitzgerald Mary
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of TNSN96035A1 publication Critical patent/TNSN96035A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)

Abstract

LES DERIVES DE LA N-(3-BENZOFURANNYL) UREE SONT PREPARES PAR LA REACTION DE BENZOFURANNE A SUBSTITUTION 3-AMINO AVEC DES ISOCYANATES OU DES ISOTHIOCYANATES SUBSTITUES APPROPRIES. LES RESIVES DE LA N-3-( BENZOFURANNYL) UREE PEUVENT ETRE UTILISES COMME PRINCIPES ACTIFS DANS DES MEDICAMENTS DESTINES EN PARTICULIER AU TRAITEMENT DES PROCESSUS INFLAMMATOIRES AIGUS ET CHRONIQUES
TNTNSN96035A 1995-03-06 1996-03-04 Derives de n-(3-benzofurannyl) uree TNSN96035A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (1)

Publication Number Publication Date
TNSN96035A1 true TNSN96035A1 (fr) 2005-03-15

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96035A TNSN96035A1 (fr) 1995-03-06 1996-03-04 Derives de n-(3-benzofurannyl) uree

Country Status (42)

Country Link
US (2) US6399657B1 (fr)
EP (1) EP0731099B1 (fr)
JP (1) JP3204901B2 (fr)
KR (2) KR100405579B1 (fr)
CN (2) CN1176651C (fr)
AR (1) AR002710A1 (fr)
AT (1) ATE193704T1 (fr)
BG (2) BG62732B1 (fr)
BR (1) BR9600930A (fr)
CA (1) CA2170824A1 (fr)
CO (1) CO4370145A1 (fr)
CZ (1) CZ66796A3 (fr)
DE (1) DE69608721T2 (fr)
DK (1) DK0731099T3 (fr)
DZ (1) DZ1998A1 (fr)
EE (1) EE03921B1 (fr)
ES (1) ES2147320T3 (fr)
FI (1) FI960998A (fr)
GB (1) GB9504460D0 (fr)
GR (1) GR3034240T3 (fr)
HK (1) HK1013285A1 (fr)
HR (1) HRP960071B1 (fr)
HU (1) HU222282B1 (fr)
IL (1) IL117349A (fr)
MA (1) MA23815A1 (fr)
MY (1) MY117526A (fr)
NO (1) NO313672B1 (fr)
NZ (1) NZ286107A (fr)
PE (1) PE43597A1 (fr)
PL (1) PL189206B1 (fr)
PT (1) PT731099E (fr)
RO (1) RO116622B1 (fr)
RU (1) RU2162845C2 (fr)
SI (1) SI0731099T1 (fr)
SK (1) SK281817B6 (fr)
SV (1) SV1996000015A (fr)
TN (1) TNSN96035A1 (fr)
TR (1) TR199600177A2 (fr)
TW (1) TW336934B (fr)
UA (1) UA46714C2 (fr)
YU (1) YU49359B (fr)
ZA (1) ZA961774B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) * 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
WO2000027802A1 (fr) * 1998-11-12 2000-05-18 Ariad Pharmaceuticals, Inc. Inhibiteurs de transduction de signaux bicycliques, compositions les contenant et utilisation de ces dernieres
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
GB2350109A (en) 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
EP1478639A1 (fr) 2002-02-22 2004-11-24 Bayer Pharmaceuticals Corporation Heterocycles tricycliques fusionnes utilises dans le traitement de troubles hyperproliferatifs
JP4206382B2 (ja) * 2002-11-19 2009-01-07 アキリオン ファーマシューティカルズ，インコーポレーテッド 置換されたアリールチオウレアおよび関連化合物；ウイルス複製のインヒビター
AU2003303678A1 (en) 2003-01-03 2004-08-10 Genzyme Corporation Urea derivatives and their use as anti-inflammatory agents
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (fr) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. Nouveau dérivé de furopyridine, composition pharmaceutique comprenant le dérivé et utilisation du dérivé ou de la composition
BRPI0713768A2 (pt) 2006-07-05 2012-10-30 Nycomed Gmbh combinação de inibidores de reductase de hmg-coa com inibidores de fosfodiesterase 4 para o tratamento de doenças pulmonares inflamatórias
US20140057978A1 (en) 2011-03-17 2014-02-27 Algiax Pharmaceuticals Gmbh Novel use of benzofuranylsulfonates
WO2013156232A1 (fr) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Utilisation de benzofuranylsulfonates dans la douleur neuropathique
JP6488000B2 (ja) 2014-03-18 2019-03-20 アルジアックス ファーマシューティカルズ ゲーエムベーハー ２−シアノ−３−シクロプロピル−３−ヒドロキシ−ｎ−アリール−チオアクリルアミド誘導体
EP3165224A1 (fr) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Utilisation d'inhibiteurs de pde4 pour la prophylaxie et/ou la thérapie de la dyslipoproteinémie et des troubles apparentés
WO2017089347A1 (fr) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Procédés et compositions pharmaceutiques pour le traitement de mélanomes résistant aux inhibiteurs de braf
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (fr) 2020-12-22 2022-06-29 Paul Scherrer Institut Procédé de production d'optique à rapport de forme élevé en forme de ventilateur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559687B2 (en) * 1981-07-01 1987-03-19 Upjohn Company, The Pyridinyl-and imidazolyl-benzofurane and benzothiophenes
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
EP0146243A1 (fr) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Inhibiteurs de la lipoxygénase
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
UA46714C2 (uk) 2002-06-17
TR199600177A2 (tr) 1996-10-21
BR9600930A (pt) 1997-12-30
PL189206B1 (pl) 2005-07-29
HU222282B1 (hu) 2003-05-28
DE69608721T2 (de) 2000-10-05
RO116622B1 (ro) 2001-04-30
EP0731099B1 (fr) 2000-06-07
SI0731099T1 (en) 2000-08-31
YU49359B (sh) 2005-09-19
CO4370145A1 (es) 1996-10-07
BG100396A (bg) 1996-12-31
CN1134419A (zh) 1996-10-30
GR3034240T3 (en) 2000-12-29
NO313672B1 (no) 2002-11-11
GB9504460D0 (en) 1995-04-26
MA23815A1 (fr) 1996-10-01
NZ286107A (en) 1998-08-26
AU4582896A (en) 1996-09-19
US6399657B1 (en) 2002-06-04
CZ66796A3 (en) 1996-09-11
CN1313284A (zh) 2001-09-19
PL313070A1 (en) 1996-09-16
HRP960071A2 (en) 1997-12-31
NO960884L (no) 1996-09-09
HK1013285A1 (en) 1999-08-20
BG62732B1 (bg) 2000-06-30
NO960884D0 (no) 1996-03-05
ES2147320T3 (es) 2000-09-01
US20030109578A1 (en) 2003-06-12
EE03921B1 (et) 2002-12-16
SK281817B6 (sk) 2001-08-06
EE9600030A (et) 1996-10-15
MY117526A (en) 2004-07-31
PE43597A1 (es) 1997-12-26
PT731099E (pt) 2000-11-30
FI960998A0 (fi) 1996-03-04
IL117349A (en) 2002-09-12
JP3204901B2 (ja) 2001-09-04
KR100405579B1 (ko) 2004-03-19
HUP9600549A2 (en) 1997-07-28
US6677372B2 (en) 2004-01-13
KR960034194A (ko) 1996-10-22
SK29796A3 (en) 1996-10-02
KR100438633B1 (ko) 2004-07-02
YU13396A (sh) 1999-06-15
ATE193704T1 (de) 2000-06-15
CN1176651C (zh) 2004-11-24
AU705667B2 (en) 1999-05-27
SV1996000015A (es) 1997-02-17
ZA961774B (en) 1996-09-17
TW336934B (en) 1998-07-21
HU9600549D0 (en) 1996-04-29
DE69608721D1 (de) 2000-07-13
DZ1998A1 (fr) 2002-07-20
HRP960071B1 (en) 2001-04-30
JPH08253466A (ja) 1996-10-01
RU2162845C2 (ru) 2001-02-10
AR002710A1 (es) 1998-04-29
CA2170824A1 (fr) 1996-09-07
EP0731099A1 (fr) 1996-09-11
IL117349A0 (en) 1996-07-23
HUP9600549A3 (en) 1998-04-28
DK0731099T3 (da) 2000-09-25
FI960998A (fi) 1996-09-07

Similar Documents

Publication Publication Date Title
TNSN96035A1 (fr) Derives de n-(3-benzofurannyl) uree
DE59511002D1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
ES2145913T3 (es) Inhibidores de metaloproteasas.
IS4338A (is) Arabínosýlansundrandi ensím
DE59510626D1 (de) Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen
DE69607827D1 (de) Herbizide zusammensetzungen von 4-benzoylisoxazolen oder 2-cyano-1,3-dionherbiziden und antidots für diese
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
ATE215373T1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
TNSN96007A1 (fr) Purine - 6 - ones 2,9 - disubstituees
TNSN90009A1 (fr) Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv
TNSN96005A1 (en) 2-(2-n-alcoxyphenyl)-purine-6-ones 9-substituees
TNSN96016A1 (fr) Utilisation de phenylcyclohexylcarboxamides
DE69832176D1 (de) Arzneimittel gegen diabetes-komplikationen
DE69120287T2 (de) Aminosulfonylharnstoff-acat-inhibitoren
TR200100637T2 (tr) Yeni doğal ürün türevleri
CA2247198A1 (fr) Composition pharmaceutique a administration locale contenant de l'heparine
NO984572D0 (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
DE3480764D1 (de) Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen.
ATE165005T1 (de) Dextrinsulfate als anti hiv-1 wirkstoffe und diese enthaltende zubereitungen
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
ATE311869T1 (de) Zubereitungen für die behandlung und verhinderung von kardiovaskulären erkrankungen
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
EA199900998A1 (ru) Полутвердый фармацевтический препарат, содержащий декскетопрофентрометамол
NO955347D0 (no) Hormonelt middel for terapi av akne samt anvendelse derav
NO20003888L (no) Anti-enzympreparater omfattende etylendiamindiravsyre